Go-Ichi-Ni-San 2: A potential biomarker and therapeutic target in human cancers

Table 1 The expression and clinical significance of Go-Ichi-Ni-San 2 in cancer

Cancer types	Cases	Expression	Clinicopathologic parameters	Ref.
Cervical cancer	155 pairs	Upregulated	Pelvic lymph node metastasis, SCC-Ag, deep stromal invasion, vital status, recurrence	Ouyang et al[3]
Gastric adenocarcinoma	123 pairs	Upregulated	Tumor size, T stage, LN metastasis	Feng et al[6]
Glioma	120 pairs	Upregulated	Uathological grade	Shen et al[7]
Glioma	37 pairs	Upregulated	/	Chi et al[9]
Glioma	63 pairs	Upregulated	TNM stage, clinical stage	Liu et al[8]
Pancreatic cancer	74 pairs	Upregulated	Tumor size, T stage, vascular permeation	Huang et al[10]
Pancreatic cancer	46 pairs	Upregulated	/	Bu et al[11]
Ovarian cancer	30 pairs	Upregulated	/	Zhan et al[14]

TNM: Tumor nodal metastasis; LN: Lymph node; SCC-Ag: Squamous cell carcinoma antigen.